MBCT for DM Distress: a Pilot Qusai-experimental Study

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT03484689
Collaborator
(none)
20
1
1
4.6
4.4

Study Details

Study Description

Brief Summary

Background: Diabetes-related distress (DRD) is very common among people with type II diabetes mellitus (DM). DRD led to poorer DM control and may led to adverse prognosis. Yet, there is no widely accepted or recommended DRD treatment.

Mindfulness was shown to relieve psychological distress in various physical and mental conditions.

Aim: as a pilot project, we aim to determine if mindfulness-based cognitive therapy (MBCT), which is one of the widely used mindfulness program, is feasible and acceptable and may improve DRD in our Chinese population.

Method: 20 Chinese participants with suboptimally controlled DM and high DRD will be recruited to a 8- week MBCT group. Pre-group and post-group (immediate and 2-month post-group) data including DRD score, quality-of life measures will be compared.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness-based cognitive therapy MBCT
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mindfulness-based Cognitive Therapy (MBCT) for Type II Diabetes Mellitus (DM) Patients With High Diabetes Distress and Suboptimal DM Control: a Pilot Qusai-experimental Study
Actual Study Start Date :
Jul 14, 2018
Actual Primary Completion Date :
Nov 30, 2018
Actual Study Completion Date :
Nov 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: MBCT arm

8-week MBCT program

Behavioral: Mindfulness-based cognitive therapy MBCT
8-week mindfulness-based cognitive therapy

Outcome Measures

Primary Outcome Measures

  1. Rate of recruitment [From recruitment (1 April) till 20 patients are recruited (within 1 month)]

    As a pilot study, we like to determine if it is feasible to recruit the target patients and measure the relevant outcomes. The number of patient approached and the number of patient recruited will be recorded

  2. Dropout rate [Week 1 (start of MBCT, intervention) till week 8]

    The proportion of patients attending at least 6 out of 8 classes

Secondary Outcome Measures

  1. Chinese Version of Diabetes Distress Scale (CDDS-15) [At pre-group (week1), immediate post-group (week8) and 2 months post-group (week16)]

    A scale to diagnose and monitor Diabetes Related Distress. The scale ranged from score 0 to 6. The higher the score, the higher the distress.

  2. 9-item patient Health Questionnaire (PHQ-9) [At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16)]

    A scale of depression score. Higher scores signifies more severe depression. Possible score ranged from 0-27

  3. The Audit of Diabetes-Dependent Quality of Life (ADDQOL) [At pre-group (week1), immediate post-group (week8) and 2 month post-group (week16)]

    A measure of Diabetes specific quality of life. The possible score for each domain is from -9(most negative impact of diabetes) to +3 (most positive impact of diabetes). Domains include leisure work, journey, holiday, physical, family life, friendships and social life, personal relationship, sex life, physical appearance, self-confidence, motivation, reactions of other people, feelings about future, financial situation, living conditions, depend on others, freedom to eat, and freedom to drink. The total score is the weighted average of all the domain, so the total score also ranged from -9 to +3.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • received a clinical diagnosis of type II DM

  • aged >=18

  • can provide valid consent

  • can speak Cantonese

  • can read and write simple Chinese

  • HbA1c >7%

  • have CDDS score >=3

Exclusion Criteria:
  • diagnosed active mental illness

  • have severe hearing loss

  • non-Chinese

  • have active suicidal ideation as screened by Q9 of PHQ-9

  • unwilling to join at least 6 out of 8 session of MBCT

  • received mindfulness training in the past year or having regular mindfulness practice

  • received psychotherapy last year

  • severe physical illness limiting them from coming repeatedly to the group

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pok Oi Hopsital Hong Kong Hong Kong

Sponsors and Collaborators

  • Chinese University of Hong Kong

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lee Kam Pui, Clinical assistant professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT03484689
Other Study ID Numbers:
  • CREC17123
First Posted:
Apr 2, 2018
Last Update Posted:
Feb 4, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lee Kam Pui, Clinical assistant professor, Chinese University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2019